1-19 of 19
Piet Borst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 736: Combining PD1- and CTLA4-inhibiting antibodies with cisplatin or PARP inhibition in an attempt to eradicate BRCA1-deficient mouse mammary tumors

Free
Sohvi Blatter, Charlotte Guyader, Aslı Küçükosmanoğlu, Stephan Freriks, Karin de Visser, Piet Borst, Sven Rottenberg
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 736.
https://doi.org/10.1158/1538-7445.AM2015-736
Published: 01 August 2015
View articletitled, Abstract 736: Combining PD1- and CTLA4-inhibiting antibodies with cisplatin or PARP inhibition in an attempt to eradicate BRCA1-deficient mouse mammary tumors
Journal Articles

Abstract 3607: Loss-of-function screens using haploid KBM7 and HAP1 cells to identify mechanisms of anti-cancer drug resistance

Free
Nora M. Gerhards, Charlotte Guyader, Vincent A. Blomen, Aslı Küçükosmanoğlu, Olaf van Tellingen, Daniel J. Vis, Lodewyk F. Wessels, Thijn R. Brummelkamp, Piet Borst, Sven Rottenberg
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3607.
https://doi.org/10.1158/1538-7445.AM2015-3607
Published: 01 August 2015
View articletitled, Abstract 3607: Loss-of-function screens using haploid KBM7 and HAP1 cells to identify mechanisms of anti-cancer drug resistance
Journal Articles

BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance

Free
Janneke E. Jaspers, Wendy Sol, Ariena Kersbergen, Andreas Schlicker, Charlotte Guyader, Guotai Xu, Lodewyk Wessels, Piet Borst, Jos Jonkers, Sven Rottenberg
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (4): 732–741.
https://doi.org/10.1158/0008-5472.CAN-14-0839
Published: 15 February 2015
View articletitled, BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance
Open the PDF for BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance in another window
Includes: Supplementary data
Journal Articles

Abstract 3771: Splenic macrophages induce chemotherapy resistance via DNA damage repair

Free
Julia M. Houthuijzen, Laura G.M. Daenen, Jeanine M.L. Roodhart, Klaas M. Govaert, Michelle E. Smith, Juergen Thomale, Sahar J. Sadatmand, Hilde Rosing, Fabian Kruse, Nico van Rooijen, Jos H. Beijnen, Piet Borst, Sven Rottenberg, Bodduluri Haribabu, Emile E. Voest
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3771.
https://doi.org/10.1158/1538-7445.AM2014-3771
Published: 01 October 2014
View articletitled, Abstract 3771: Splenic macrophages induce chemotherapy resistance via DNA damage repair
Journal Articles

Abstract 5584: Finding predictive markers for tumor response to classical cytotoxic drugs.

Free
Piet Borst, Sven Rottenberg
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5584.
https://doi.org/10.1158/1538-7445.AM2013-5584
Published: 15 April 2013
View articletitled, Abstract 5584: Finding predictive markers for tumor response to classical cytotoxic drugs.
Journal Articles

Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors

Free
Sven Rottenberg, Marieke A. Vollebergh, Bas de Hoon, Jorma de Ronde, Philip C. Schouten, Ariena Kersbergen, Serge A.L. Zander, Marina Pajic, Janneke E. Jaspers, Martijn Jonkers, Martin Lodén, Wendy Sol, Eline van der Burg, Jelle Wesseling, Jean-Pierre Gillet, Michael M. Gottesman, Joost Gribnau, Lodewyk Wessels, Sabine C. Linn, Jos Jonkers, Piet Borst
Journal: Cancer Research
Cancer Res (2012) 72 (9): 2350–2361.
https://doi.org/10.1158/0008-5472.CAN-11-4201
Published: 30 April 2012
View articletitled, Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
Open the PDF for Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract LB-392: Loss of Rev7 causes PARP inhibitor resistance in BRCA1;p53-deficient mouse mammary tumor cells

Free
Guotai Xu, Peter Bouwman, Janneke Jaspers, Mark Pieterse, Ariena Kersbergen, Jos Jonkers, Piet Borst, Sven Rottenberg
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-392.
https://doi.org/10.1158/1538-7445.AM2012-LB-392
Published: 15 April 2012
View articletitled, Abstract LB-392: Loss of Rev7 causes PARP inhibitor resistance in BRCA1;p53-deficient mouse mammary tumor cells
Journal Articles

Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan

Free
Serge A.L. Zander, Ariena Kersbergen, Eline van der Burg, Niels de Water, Olaf van Tellingen, Sjöfn Gunnarsdottir, Janneke E. Jaspers, Marina Pajic, Anders O.H. Nygren, Jos Jonkers, Piet Borst, Sven Rottenberg
Journal: Cancer Research
Cancer Res (2010) 70 (4): 1700–1710.
https://doi.org/10.1158/0008-5472.CAN-09-3367
Published: 14 February 2010
View articletitled, Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan
Open the PDF for Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan in another window
Includes: Supplementary data
Journal Articles

Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer

Free
Marina Pajic, Jayasree K. Iyer, Ariena Kersbergen, Eline van der Burg, Anders O.H. Nygren, Jos Jonkers, Piet Borst, Sven Rottenberg
Journal: Cancer Research
Cancer Res (2009) 69 (16): 6396–6404.
https://doi.org/10.1158/0008-5472.CAN-09-0041
Published: 12 August 2009
View articletitled, Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
Open the PDF for Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer in another window
Includes: Supplementary data
Journal Articles

The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates

Free
Peter Wielinga, Jan Hendrik Hooijberg, Sjofn Gunnarsdottir, Ietje Kathmann, Glen Reid, Noam Zelcer, Kasper van der Born, Marcel de Haas, Ingrid van der Heijden, Gertjan Kaspers, Jan Wijnholds, Gerrit Jansen, Godefridus Peters, Piet Borst
Journal: Cancer Research
Cancer Res (2005) 65 (10): 4425–4430.
https://doi.org/10.1158/0008-5472.CAN-04-2810
Published: 16 May 2005
View articletitled, The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates
Open the PDF for The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates in another window
Journal Articles

Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles: Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions

Free
Pauline Breedveld, Noam Zelcer, Dick Pluim, Özgür Sönmezer, Matthijs M. Tibben, Jos H. Beijnen, Alfred H. Schinkel, Olaf van Tellingen, Piet Borst, Jan H. M. Schellens
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5804–5811.
https://doi.org/10.1158/0008-5472.CAN-03-4062
Published: 16 August 2004
View articletitled, Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles: Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions
Open the PDF for Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles: Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions in another window
Journal Articles

Multidrug resistance protein 4 (Mrp4) is expressed at the blood-cerebrospinal and blood-brain barriers and restricts topotecan brain penetration

Free
Markos Leggas, Masashi Adachi, Daxi Sun, Guoqing Du, Kelly E. Mercer, John C. Panetta, Yanli Zhuang, George L. Scheffer, Rik J. Scheper, Peter Wielinga, Piet Borst, Clinton F. Stewart, John D. Schuetz
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 115–116.
Published: 01 April 2004
View articletitled, Multidrug resistance protein 4 (Mrp4) is expressed at the blood-cerebrospinal and blood-brain barriers and restricts topotecan brain penetration
Journal Articles

Specific Detection of Multidrug Resistance Proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-Glycoprotein with a Panel of Monoclonal Antibodies

Free
George L. Scheffer, Marcel Kool, Marc Heijn, Marcel de Haas, Adriana C. L. M. Pijnenborg, Jan Wijnholds, Ardy van Helvoort, Mariska C. de Jong, Jan H. Hooijberg, Carla A. A. M. Mol, Marcel van der Linden, J. Marleen L. de Vree, Paul van der Valk, Ronald P. J. Oude Elferink, Piet Borst, Rik J. Scheper
Journal: Cancer Research
Cancer Res (2000) 60 (18): 5269–5277.
Published: 01 September 2000
View articletitled, Specific Detection of Multidrug Resistance Proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-Glycoprotein with a Panel of Monoclonal Antibodies
Open the PDF for Specific Detection of Multidrug Resistance Proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-Glycoprotein with a Panel of Monoclonal Antibodies in another window
Journal Articles

Antifolate Resistance Mediated by the Multidrug Resistance Proteins MRP1 and MRP2

Free
Jan Hendrik Hooijberg, Henk J. Broxterman, Marcel Kool, Yehuda G. Assaraf, Godefridus J. Peters, Paul Noordhuis, Rik J. Scheper, Piet Borst, Herbert M. Pinedo, Gerrit Jansen
Journal: Cancer Research
Cancer Res (1999) 59 (11): 2532–2535.
Published: 01 June 1999
View articletitled, Antifolate Resistance Mediated by the Multidrug Resistance Proteins MRP1 and MRP2
Open the PDF for Antifolate Resistance Mediated by the Multidrug Resistance Proteins MRP1 and MRP2 in another window
Journal Articles

Expression of Human MRP6, a Homologue of the Multidrug Resistance Protein Gene MRP1, in Tissues and Cancer Cells

Free
Marcel Kool, Marcel van der Linden, Marcel de Haas, Frank Baas, Piet Borst
Journal: Cancer Research
Cancer Res (1999) 59 (1): 175–182.
Published: 01 January 1999
View articletitled, Expression of Human MRP6, a Homologue of the Multidrug Resistance Protein Gene MRP1, in Tissues and Cancer Cells
Open the PDF for Expression of Human MRP6, a Homologue of the Multidrug Resistance Protein Gene MRP1, in Tissues and Cancer Cells in another window
Journal Articles

Analysis of Expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, Homologues of the Multidrug Resistance-associated Protein Gene (MRP1), in Human Cancer Cell Lines

Free
Marcel Kool, Marcel de Haas, George L. Scheffer, Rik J. Scheper, Michiel J.T. van Eijk, Jenneke A. Juijn, Frank Baas, Piet Borst
Journal: Cancer Research
Cancer Res (1997) 57 (16): 3537–3547.
Published: 01 August 1997
View articletitled, Analysis of Expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, Homologues of the Multidrug Resistance-associated Protein Gene (MRP1), in Human Cancer Cell Lines
Open the PDF for Analysis of Expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, Homologues of the Multidrug Resistance-associated Protein Gene (MRP1), in Human Cancer Cell Lines in another window
Journal Articles

Analysis of the Expression of MRP, the Gene for a New Putative Transmembrane Drug Transporter, in Human Multidrug Resistant Lung Cancer Cell Lines

Free
Guido J. R. Zaman, Carolina H. M. Versantvoort, Jaap J. M. Smit, Elisabeth W. H. M. Eijdems, Marcel de Haas, Alexander J. Smith, Henricus J. Broxterman, Nanno H. Mulder, Elisabeth G. E. de Vries, Frank Baas, Piet Borst
Journal: Cancer Research
Cancer Res (1993) 53 (8): 1747–1750.
Published: 01 April 1993
View articletitled, Analysis of the Expression of MRP, the Gene for a New Putative Transmembrane Drug Transporter, in Human Multidrug Resistant Lung Cancer Cell Lines
Open the PDF for Analysis of the Expression of MRP, the Gene for a New Putative Transmembrane Drug Transporter, in Human Multidrug Resistant Lung Cancer Cell Lines in another window
Journal Articles

Characterization of the Human MDR3 P-Glycoprotein and Its Recognition by P-Glycoprotein-specific Monoclonal Antibodies

Free
Alfred H. Schinkel, Marjo E. M. Roelofs, Piet Borst
Journal: Cancer Research
Cancer Res (1991) 51 (10): 2628–2635.
Published: 01 May 1991
View articletitled, Characterization of the Human MDR3 P-Glycoprotein and Its Recognition by P-Glycoprotein-specific Monoclonal Antibodies
Open the PDF for Characterization of the Human MDR3 P-Glycoprotein and Its Recognition by P-Glycoprotein-specific Monoclonal Antibodies in another window
Journal Articles

Multidrug Resistance Phenotype of Human BRO Melanoma Cells Transfected with a Wild-Type Human mdr1 Complementary DNA

Free
Carsten R. Lincke, Alexander M. van der Bliek, Gerrit J. Schuurhuis, Trijntje van der Velde-Koerts, Jaap J. M. Smit, Piet Borst
Journal: Cancer Research
Cancer Res (1990) 50 (6): 1779–1785.
Published: 01 March 1990
View articletitled, Multidrug Resistance Phenotype of Human BRO Melanoma Cells Transfected with a Wild-Type Human mdr1 Complementary DNA
Open the PDF for Multidrug Resistance Phenotype of Human BRO Melanoma Cells Transfected with a Wild-Type Human mdr1 Complementary DNA in another window